SBRT, or stereotactic body radiation therapy, is a type of radiation treatment that delivers very high doses of precisely targeted radiation to a tumor in just one to five sessions. Unlike conventional radiation therapy, which spreads smaller doses across 25 to 40 sessions over several weeks, SBRT concentrates enough energy to essentially ablate (destroy) the tumor in a fraction of the time. It’s most commonly used for small, early-stage cancers in the lungs, liver, prostate, pancreas, kidney, and spine.
How SBRT Differs From Standard Radiation
Conventional radiation therapy works by damaging tumor DNA in repeated small doses, relying on the idea that cancer cells are worse at repairing themselves than healthy cells. Over dozens of sessions, cancer cells accumulate enough damage to die. SBRT takes a fundamentally different approach. It delivers doses so high, typically 8 to 12 Gray per session compared to about 2 Gray in conventional treatment, that tumor cells are directly destroyed rather than slowly worn down. The total dose usually ranges from 40 to 60 Gray delivered across five or fewer sessions within about two weeks.
This intensity changes the biology of what happens inside the tumor. At these high doses, the treatment doesn’t just kill cancer cells directly. It also damages the tiny blood vessels feeding the tumor and appears to trigger an immune response against remaining cancer cells. These additional effects help explain why SBRT’s clinical results are better than traditional radiation models would predict.
What SBRT Treats
The most established use of SBRT is for early-stage non-small cell lung cancer in patients who can’t undergo surgery, where it has become the standard of care. Local tumor control rates consistently exceed 90%, meaning the treated tumor stays controlled in more than nine out of ten patients. SBRT is also used for tumors in the liver, pancreas, prostate, kidney, colon, and along the spine. In general, the best candidates have tumors that are relatively small and well-defined rather than large or diffuse.
For lung tumors specifically, the clearest candidates have tumors smaller than 4 centimeters that sit at least 2 centimeters away from major airways like the main bronchus. Tumors closer to central airway structures or larger than 4 centimeters can still be treated, but the risk-benefit calculation becomes more nuanced. A very large tumor pressed directly against the airway, for example a 7-centimeter tumor touching the carina (where the windpipe splits), would rarely be treated with SBRT.
SBRT Compared to Surgery
For early-stage lung cancer patients healthy enough for an operation, surgery still produces better long-term survival overall. A large analysis of nearly 30,000 patients found that three-year overall survival was significantly higher with surgery. However, local tumor control, meaning the ability to eliminate the treated tumor itself, was not significantly different between the two approaches. SBRT also causes less short-term disruption. Patients experience fewer complications in the weeks after treatment and report better quality of life during recovery compared to surgical patients. This makes SBRT particularly valuable for older adults or people with other health conditions that make surgery risky.
How the Treatment Works in Practice
Before treatment begins, you’ll go through a planning session called a simulation. The radiation team creates detailed imaging of your tumor and surrounding anatomy, often using specialized CT scans. If your tumor moves when you breathe, as liver and lung tumors do, the team will choose a strategy to account for that motion. Options include breath-hold techniques, where you hold your breath at a consistent point during each radiation burst; respiratory gating, where the machine only fires radiation when your breathing reaches a specific phase; abdominal compression, which limits how much the tumor moves; or real-time tracking, where the machine follows the tumor’s position continuously.
Each treatment session takes about 30 minutes, covering both setup and radiation delivery. During setup, the team uses onboard imaging (typically a cone-beam CT scan taken right on the treatment table) to verify the tumor’s exact position before radiation begins. Some centers also use implanted markers or clips to help pinpoint the target. You lie still on the treatment table, and the machine delivers radiation from multiple angles, concentrating the dose on the tumor while minimizing exposure to surrounding tissue. The entire course of treatment wraps up within about two weeks.
Machines Used to Deliver SBRT
SBRT can be delivered by several different types of machines, and the choice often depends on what a treatment center has available and where the tumor is located. The two main categories are robotic systems and conventional linear accelerators adapted for stereotactic use.
The CyberKnife is a robotic system that mounts a small radiation source on a movable arm, allowing it to aim from hundreds of different angles and track tumor movement in real time. It excels at creating steep dose gradients, meaning it can deliver a very high dose to the tumor while dropping off sharply just millimeters away, which helps protect nearby critical structures. Conventional linear accelerators like the Varian TrueBeam and Varian Edge deliver SBRT using a technique called volumetric arc therapy, where the machine rotates around you in smooth arcs. These systems tend to be better at sparing structures farther from the tumor and can deliver treatments more efficiently. Both approaches produce excellent clinical results.
Side Effects by Treatment Area
Because SBRT targets such a small area, side effects tend to be milder and more localized than with conventional radiation. The most common short-term effect is fatigue, which typically lasts a few days after treatment. Swelling near the treatment site can temporarily increase pain. If you’re being treated near the bowel or liver, nausea is possible for a short period. Skin in the treatment area may become irritated, itchy, or dry.
Late side effects are less common but can appear months or years later. These include weakened bones near the treatment site, changes in bowel or bladder habits, swelling in the arms or legs (lymphedema), or nerve changes near the spine. Very rarely, a new cancer can develop in the treated area years later. The overall side effect profile is one of SBRT’s main advantages: because so few treatment sessions are needed and the radiation is so precisely focused, healthy tissue gets far less cumulative exposure than it would during a conventional radiation course.